Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jennifer B. DamicoSVP & Controller | PfizerPFE | Open-market sale | 06/09 | 06/10 | 2,000 sh | $25.70 | $51,400 | −6.0% |
Jennifer B. DamicoSVP & Controller | PfizerPFE | Open-market sale | 25/03/04 | 25/03/06 | 2,500 sh | $25.93 | $64,825 | −17.4% |
Ronald E. BlaylockDirector | PfizerPFE | Open-market buy | 25/02/13 | 25/02/14 | 19,457 sh | $25.65 | $499,072.05 | +235.8% |
Scott GottliebDirector | PfizerPFE | Open-market buy | 24/10/30 | 24/10/31 | 1,000 sh | $28.24 | $28,240 | +11.1% |
Jennifer B. DamicoSVP & Controller | PfizerPFE | Open-market sale | 24/08/13 | 24/08/14 | 5,154 sh | $28.66 | $147,713.64 | −37.5% |
Scott GottliebDirector | PfizerPFE | Open-market buy | 23/12/15 | 23/12/19 | 3,000 sh | $26.47 | $79,410 | +50.0% |
Director | PfizerPFE | Open-market buy | 23/05/05–23/05/08 | 23/05/09 | 2,000 sh2 trades | $38.51avg. | $77,010 | +50.0% |
Jennifer B. DamicoSVP & Controller | PfizerPFE | Open-market sale | 23/03/15 | 23/03/17 | 9,912 sh | $40.02 | $396,678.24 | −52.4% |
